Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy

BACKGROUND: Testicular germ cell tumor (TGCT) is the most curable solid tumor and most common cancer among men 18-39 years. While cisplatin-based chemotherapy has significantly lengthened the survival of patients with TGCT, it is associated with a high rate of thromboembolic events (TEE). AIM: To su...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Lisa B E, Daniels, Michael W, Mar, Nataliya, Rezazadeh Kalebasty, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968108/
https://www.ncbi.nlm.nih.gov/pubmed/33767973
http://dx.doi.org/10.5306/wjco.v12.i3.183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968108/
https://www.ncbi.nlm.nih.gov/pubmed/33767973
http://dx.doi.org/10.5306/wjco.v12.i3.183

Ejemplares similares